The FDA has cleared Intuitive’s (NASDAQ:ISRG) two innovative technologies for two of the company’s da Vinci surgical systems to help improve procedures that require sealing.
Intuitive’s E-100 generator is its first internally developed robotic generator to power two key instruments on the da Vinci X and Xi systems.
Vessel Sealer Extend is the flagship instrument in the da Vinci energy sealing portfolio, and the new SynchroSeal instrument offers enhanced capabilities in general surgery.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.